Discontinuation of CDC’s Distribution of Intravenous Artesunate as Commercial Drug is Widely Available in the United States
CDC has discontinued its distribution of intravenous artesunate for treatment of severe malaria in the U.S. as of September 30, 2022. Commercial intravenous artesunate, Artesunate for InjectionTM, is available in adequate supply from major drug distributors. Severe malaria can rapidly progress to death. Having a plan for rapid diagnosis and […]
Defeating meningitis by 2030
Despite significant progress over the last few decades, meningitis remains a much-feared disease worldwide with a high case fatality rate and a propensity to cause epidemics that present a major challenge for health systems, economies and society. Meningitis caused an estimated 250 000 deaths in 2019, leaving one in five […]
Backslide in Global Childhood Vaccinations
Worldwide childhood vaccinations continued to decline in 2021, fueled by a multitude of factors from COVID-19 to challenging immunization settings, according to a statement by the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF). The percentage of children who received 3 doses of the vaccine against diphtheria-tetanus-pertussis (DTP)—a marker […]
COVID-19 Integrated County View
This site provides an integrated, county view of key data for monitoring the COVID-19 pandemic in the United States. It allows for the exploration of standardized data across the country.§ The footnotes describe each data source and the methods used for calculating the metrics. For the most complete and up-to-date data […]
Preventive Medication for COVID-19 Infection
Tixagevimab-cilgavimab is a combination medication to help prevent COVID-19 infection. Tixagevimab-cilgavimab (Evusheld) consists of 2 long-acting monoclonal antibodies that bind to the spike protein of the virus that causes COVID-19 to prevent it from infecting human cells. When Can Tixagevimab-Cilgavimab Be Given? Tixagevimab-cilgavimab is not a treatment for COVID-19 and […]
Despite Its Fan Base, Newly Authorized “Traditional” Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US
To say that Krystal Lashley went to great lengths to get the Novavax COVID-19 vaccine (NVX-CoV2373) would be a gross understatement. In April, Lashley traveled roughly 3700 miles from her home in Metuchen, New Jersey, to a pharmacy in Paris, France, for her first dose. She then flew to the […]
Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error
In a recent study published in Indoor Air, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC). Background […]
Enteroviruses
Most people who get infected with non-polio enteroviruses do not get sick, or they only have mild illness, like the common cold. Symptoms of mild illness can include fever, runny nose, sneezing, cough, skin rash, mouth blisters, and body and muscle aches. Three better-known non-polio enteroviruses are enterovirus D68 (EV-D68), […]
Clinical management of COVID-19: Living guideline, 15 September 2022
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ […]